<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Impedimed Limited — News on 6ix</title>
<link>https://6ix.com/company/impedimed-ltd</link>
<description>Latest news and press releases for Impedimed Limited on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Mon, 04 May 2026 05:16:06 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/impedimed-ltd" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo683666a278dffbe2df15e04d.webp</url>
<title>Impedimed Limited</title>
<link>https://6ix.com/company/impedimed-ltd</link>
</image>
<item>
<title>Equity Raising Investor Presentation</title>
<link>https://6ix.com/company/impedimed-ltd/news/equity-raising-investor-presentation-22</link>
<guid isPermaLink="true">https://6ix.com/company/impedimed-ltd/news/equity-raising-investor-presentation-22</guid>
<pubDate>Mon, 04 May 2026 05:16:06 GMT</pubDate>
<description>Equity Raising Investor Presentation</description>
</item>
<item>
<title>Quarterly Activities Report and Appendix 4C - Mar-2026 Qtr</title>
<link>https://6ix.com/company/impedimed-ltd/news/quarterly-activities-report-and-appendix-4c-mar-2026-qtr</link>
<guid isPermaLink="true">https://6ix.com/company/impedimed-ltd/news/quarterly-activities-report-and-appendix-4c-mar-2026-qtr</guid>
<pubDate>Thu, 30 Apr 2026 02:40:12 GMT</pubDate>
<description>Quarterly Activities Report and Appendix 4C - Mar-2026 Qtr</description>
</item>
<item>
<title>ImpediMed Appoints Erik Anderson as Chief Executive Officer</title>
<link>https://6ix.com/company/impedimed-ltd/news/impedimed-appoints-erik-anderson-as-chief-executive-officer</link>
<guid isPermaLink="true">https://6ix.com/company/impedimed-ltd/news/impedimed-appoints-erik-anderson-as-chief-executive-officer</guid>
<pubDate>Tue, 07 Apr 2026 20:29:00 GMT</pubDate>
<description>ImpediMed, a leader in the development and commercialization of medical technologies to clinically monitor and manage fluid and body composition, and its Board of Directors have announced the appointment of Erik Anderson as Managing Director and Chief Executive Officer. Anderson, who joined the company's Board of Directors in February 2026, succeeds Dr. Parmjot Bains. His appointment is effective April 7, 2026.</description>
</item>
<item>
<title>Appointment of CEO/Managing Director</title>
<link>https://6ix.com/company/impedimed-ltd/news/appointment-of-ceomanaging-director-1</link>
<guid isPermaLink="true">https://6ix.com/company/impedimed-ltd/news/appointment-of-ceomanaging-director-1</guid>
<pubDate>Tue, 07 Apr 2026 02:53:06 GMT</pubDate>
<description>Appointment of CEO/Managing Director</description>
</item>
<item>
<title>FY26 Half Year Financial Results</title>
<link>https://6ix.com/company/impedimed-ltd/news/fy26-half-year-financial-results</link>
<guid isPermaLink="true">https://6ix.com/company/impedimed-ltd/news/fy26-half-year-financial-results</guid>
<pubDate>Thu, 26 Feb 2026 02:51:07 GMT</pubDate>
<description>FY26 Half Year Financial Results</description>
</item>
<item>
<title>Appendix 4D and Interim Financial Report</title>
<link>https://6ix.com/company/impedimed-ltd/news/appendix-4d-and-interim-financial-report-48</link>
<guid isPermaLink="true">https://6ix.com/company/impedimed-ltd/news/appendix-4d-and-interim-financial-report-48</guid>
<pubDate>Thu, 26 Feb 2026 02:51:07 GMT</pubDate>
<description>Appendix 4D and Interim Financial Report</description>
</item>
<item>
<title>ImpediMed Appoints Medical Technology Commercialization Expert Erik Anderson to Board of Directors</title>
<link>https://6ix.com/company/impedimed-ltd/news/impedimed-appoints-medical-technology-commercialization-expert-erik-anderson-to-board-of-directors</link>
<guid isPermaLink="true">https://6ix.com/company/impedimed-ltd/news/impedimed-appoints-medical-technology-commercialization-expert-erik-anderson-to-board-of-directors</guid>
<pubDate>Wed, 25 Feb 2026 23:07:00 GMT</pubDate>
<description>ImpediMed, a leader in the development and commercialization of medical technologies to clinically monitor and manage fluid and body composition, today announced the appointment of Erik Anderson to its Board of Directors.</description>
</item>
<item>
<title>Quarterly Activities Report and Appendix 4C - Dec-2025</title>
<link>https://6ix.com/company/impedimed-ltd/news/quarterly-activities-report-and-appendix-4c-dec-2025</link>
<guid isPermaLink="true">https://6ix.com/company/impedimed-ltd/news/quarterly-activities-report-and-appendix-4c-dec-2025</guid>
<pubDate>Thu, 29 Jan 2026 02:38:21 GMT</pubDate>
<description>Quarterly Activities Report and Appendix 4C - Dec-2025</description>
</item>
<item>
<title>Quarterly Activities Report and Appendix 4C - Sep-2025 Qtr</title>
<link>https://6ix.com/company/impedimed-ltd/news/quarterly-activities-report-and-appendix-4c-sep-2025-qtr</link>
<guid isPermaLink="true">https://6ix.com/company/impedimed-ltd/news/quarterly-activities-report-and-appendix-4c-sep-2025-qtr</guid>
<pubDate>Thu, 30 Oct 2025 01:39:23 GMT</pubDate>
<description>Quarterly Activities Report and Appendix 4C - Sep-2025 Qtr</description>
</item>
<item>
<title>Major US health insurer publishes positive coverage</title>
<link>https://6ix.com/company/impedimed-ltd/news/major-us-health-insurer-publishes-positive-coverage</link>
<guid isPermaLink="true">https://6ix.com/company/impedimed-ltd/news/major-us-health-insurer-publishes-positive-coverage</guid>
<pubDate>Thu, 02 Oct 2025 02:59:14 GMT</pubDate>
<description>Major US health insurer publishes positive coverage</description>
</item>
<item>
<title>Appendix 4E</title>
<link>https://6ix.com/company/impedimed-ltd/news/appendix-4e-116</link>
<guid isPermaLink="true">https://6ix.com/company/impedimed-ltd/news/appendix-4e-116</guid>
<pubDate>Thu, 28 Aug 2025 02:40:06 GMT</pubDate>
<description>Appendix 4E</description>
</item>
<item>
<title>Quarterly Activities Report and Appendix 4C - Jun-2025 Qtr</title>
<link>https://6ix.com/company/impedimed-ltd/news/quarterly-activities-report-and-appendix-4c-jun-2025-qtr</link>
<guid isPermaLink="true">https://6ix.com/company/impedimed-ltd/news/quarterly-activities-report-and-appendix-4c-jun-2025-qtr</guid>
<pubDate>Thu, 31 Jul 2025 02:43:41 GMT</pubDate>
<description>Quarterly Activities Report and Appendix 4C - Jun-2025 Qtr</description>
</item>
<item>
<title>Q4 FY25 sales and growth capital facility update</title>
<link>https://6ix.com/company/impedimed-ltd/news/q4-fy25-sales-and-growth-capital-facility-update</link>
<guid isPermaLink="true">https://6ix.com/company/impedimed-ltd/news/q4-fy25-sales-and-growth-capital-facility-update</guid>
<pubDate>Wed, 16 Jul 2025 04:06:04 GMT</pubDate>
<description>Q4 FY25 sales and growth capital facility update</description>
</item>
<item>
<title>Quarterly Activities Report and Appendix 4C - Mar-2025 Qtr</title>
<link>https://6ix.com/company/impedimed-ltd/news/quarterly-activities-report-and-appendix-4c-mar-2025-qtr</link>
<guid isPermaLink="true">https://6ix.com/company/impedimed-ltd/news/quarterly-activities-report-and-appendix-4c-mar-2025-qtr</guid>
<pubDate>Wed, 30 Apr 2025 03:00:20 GMT</pubDate>
<description>Quarterly Activities Report and Appendix 4C - Mar-2025 Qtr</description>
</item>
<item>
<title>S&P DJI Announces March 2025 Quarterly Rebalance</title>
<link>https://6ix.com/company/impedimed-ltd/news/sandp-dji-announces-march-2025-quarterly-rebalance-99</link>
<guid isPermaLink="true">https://6ix.com/company/impedimed-ltd/news/sandp-dji-announces-march-2025-quarterly-rebalance-99</guid>
<pubDate>Fri, 07 Mar 2025 11:22:14 GMT</pubDate>
<description>S&P DJI Announces March 2025 Quarterly Rebalance</description>
</item>
<item>
<title>ImpediMed secures US$15 million growth capital facility</title>
<link>https://6ix.com/company/impedimed-ltd/news/impedimed-secures-usdollar15-million-growth-capital-facility</link>
<guid isPermaLink="true">https://6ix.com/company/impedimed-ltd/news/impedimed-secures-usdollar15-million-growth-capital-facility</guid>
<pubDate>Thu, 06 Feb 2025 03:44:14 GMT</pubDate>
<description>ImpediMed secures US$15 million growth capital facility</description>
</item>
<item>
<title>Quarterly Activities Report and Appendix 4C - Dec-2024 Qtr</title>
<link>https://6ix.com/company/impedimed-ltd/news/quarterly-activities-report-and-appendix-4c-dec-2024-qtr</link>
<guid isPermaLink="true">https://6ix.com/company/impedimed-ltd/news/quarterly-activities-report-and-appendix-4c-dec-2024-qtr</guid>
<pubDate>Fri, 31 Jan 2025 02:44:29 GMT</pubDate>
<description>Quarterly Activities Report and Appendix 4C - Dec-2024 Qtr</description>
</item>
<item>
<title>Presentation - Bell Potter Conference</title>
<link>https://6ix.com/company/impedimed-ltd/news/presentation-bell-potter-conference</link>
<guid isPermaLink="true">https://6ix.com/company/impedimed-ltd/news/presentation-bell-potter-conference</guid>
<pubDate>Mon, 18 Nov 2024 04:42:11 GMT</pubDate>
<description>Presentation - Bell Potter Conference</description>
</item>
<item>
<title>Investor Presentation</title>
<link>https://6ix.com/company/impedimed-ltd/news/investor-presentation-299</link>
<guid isPermaLink="true">https://6ix.com/company/impedimed-ltd/news/investor-presentation-299</guid>
<pubDate>Tue, 22 Oct 2024 01:38:23 GMT</pubDate>
<description>Investor Presentation</description>
</item>
<item>
<title>Quarterly Activities Report and Appendix 4C - Sep-2024 Qtr</title>
<link>https://6ix.com/company/impedimed-ltd/news/quarterly-activities-report-and-appendix-4c-sep-2024-qtr</link>
<guid isPermaLink="true">https://6ix.com/company/impedimed-ltd/news/quarterly-activities-report-and-appendix-4c-sep-2024-qtr</guid>
<pubDate>Tue, 22 Oct 2024 01:38:23 GMT</pubDate>
<description>Quarterly Activities Report and Appendix 4C - Sep-2024 Qtr</description>
</item>
</channel>
</rss>